title: E4orf1: a novel ligand that improves glucose disposal in cell culture.
abstract: Reducing dietary fat intake and excess adiposity, the cornerstones of behavioral treatment of insulin resistance (IR), are marginally successful over the long term. Ad36, a human adenovirus, offers a template to improve IR, independent of dietary fat intake or adiposity. Ad36 increases cellular glucose uptake via a Ras-mediated activation of phosphatidyl inositol 3-kinase(PI3K), and improves hyperglycemia in mice, despite a high-fat diet and without reducing adiposity. Ex-vivo studies suggest that Ad36 improves hyperglycemia in mice by increasing glucose uptake by adipose tissue and skeletal muscle, and by reducing hepatic glucose output. It is impractical to use Ad36 for therapeutic action. Instead, we investigated if the E4orf1 protein of Ad36, mediates its anti-hyperglycemic action. Such a candidate protein may offer an attractive template for therapeutic development. Experiment-1 determined that Ad36 'requires' E4orf1 protein to up-regulate cellular glucose uptake. Ad36 significantly increased glucose uptake in 3T3-L1 preadipocytes, which was abrogated by knocking down E4orf1 with siRNA. Experiment-2 identified E4orf1 as 'sufficient' to up-regulate glucose uptake. 3T3-L1 cells that inducibly express E4orf1, increased glucose uptake in an induction-dependent manner, compared to null vector control cells. E4orf1 up-regulated PI3K pathway and increased abundance of Ras--the obligatory molecule in Ad36-induced glucose uptake. Experiment-3: Signaling studies of cells transiently transfected with E4orf1 or a null vector, revealed that E4orf1 may activate Ras/PI3K pathway by binding to Drosophila discs-large (Dlg1) protein. E4orf1 activated total Ras and, particularly the H-Ras isoform. By mutating the PDZ domain binding motif (PBM) of E4orf1, Experiment-4 showed that E4orf1 requires its PBM to increase Ras activation or glucose uptake. Experiment-5: In-vitro, a transient transfection by E4orf1 significantly increased glucose uptake in preadipocytes, adipocytes, or myoblasts, and reduced glucose output by hepatocytes. Thus, the highly attractive anti-hyperglycemic effect of Ad36 is mirrored by E4orf1 protein, which may offer a novel ligand to develop anti-hyperglycemic drugs.
authors: Infections and Obesity Laboratory, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States of America.
authors: Emily J
authors: EJ
authors: Dhurandhar
authors: Olga
authors: O
authors: Dubuisson
authors: Nazar
authors: N
authors: Mashtalir
authors: Rashmi
authors: R
authors: Krishnapuram
authors: Vijay
authors: V
authors: Hegde
authors: Nikhil V
authors: NV
authors: Dhurandhar
mesh_terms: D041721:3T3-L1 Cells; D000256:Adenoviridae / Q000378:metabolism; D017504:Adenovirus E4 Proteins / Q000737:chemistry / Q000378:metabolism*; D017667:Adipocytes / Q000378:metabolism; D020816:Amino Acid Motifs; D000818:Animals; D018929:Cell Culture Techniques; D000074288:Discs Large Homolog 1 Protein; D005947:Glucose / Q000378:metabolism*; D056945:Hep G2 Cells; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D008024:Ligands; D051379:Mice; D032446:Myoblasts / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D000074407:SAP90-PSD95 Associated Proteins; D015398:Signal Transduction; D015854:Up-Regulation; D018631:ras Proteins / Q000378:metabolism
chemical_list: D017504:Adenovirus E4 Proteins; D000074288:Discs Large Homolog 1 Protein; C000614189:Dlg1 protein, mouse; D008024:Ligands; D009419:Nerve Tissue Proteins; D000074407:SAP90-PSD95 Associated Proteins; D019869:Phosphatidylinositol 3-Kinases; D018631:ras Proteins; D005947:Glucose